Inflammatory Bowel Disease-Associated Interleukin-33 Is Preferentially Expressed in Ulceration-Associated Myofibroblasts
Authors:
- Jürgen PollheimerJPJürgen Pollheimer
- Trine OlsenTOTrine Olsen
- Johanna BaloghJBJohanna Balogh
- Clara HammarströmCHClara Hammarström
- Tamara LoosTLTamara Loos
- Monika KasprzyckaMKMonika Kasprzycka
- Dag Reidar SørensenDSDag Reidar Sørensen
- Hogne Røed NilsenHNHogne Røed Nilsen
- Axel M. KüchlerAKAxel M. Küchler
- Morten H. VatnMVMorten H. Vatn
- Guttorm HaraldsenGHGuttorm Haraldsen
- 1 December 2010
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 177 (6) , 2804-2815
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- RIG-I-like receptors: Sensing and responding to RNA virus infectionSeminars in Immunology, 2009
- Interleukin-33 Is Biologically Active Independently of Caspase-1 CleavageJournal of Biological Chemistry, 2009
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1Proceedings of the National Academy of Sciences, 2009
- Immunological and Inflammatory Functions of the Interleukin-1 FamilyAnnual Review of Immunology, 2009
- Molecular mimicry between IL‐33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocketEMBO Reports, 2008
- IL-33 exacerbates antigen-induced arthritis by activating mast cellsProceedings of the National Academy of Sciences, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based CohortGastroenterology, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007